Stock Information
Apogee Therapeutics Inc (APGE)
Ticker Symbol: APGE
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $4,171.75 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -4.3625
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -39.09%
Latest News
-
Apogee Therapeutics (NASDAQ:APGE) Reports Q4 2025 Results, Highlights Cash Runway and Key 2026 Clinical Catalysts
Mon, Mar 2, 2026 1:20 PM
-
Apogee Therapeutics Q4 EPS $(1.03) Beats $(1.04) Estimate
Mon, Mar 2, 2026 8:27 AM
-
Apogee Therapeutics Reports 2025 Results With $902.9M Cash Runway Into 2H 2028 As Zumilokibart Phase 2 52-Week Data Nears And Phase 3 Planned For 2H 2026
Mon, Mar 2, 2026 8:17 AM
Key Financials
Financial data not available
